The pioneering Danish drugmaker was once the most valuable company in Europe, but analysts say a number of missteps reversed ...

BP will launch a review of how best to develop and monetise its oil and gas production assets and consider more cost cuts to ...

BP will review its portfolio of assets and consider further cost cuts as part of a drive to do better for shareholders, the ...

The appointment comes as the energy major slashes green spending and pivots back to oil amid pressure from investors.

BP named outsider Albert Manifold, the former boss of building materials producer CRH, as its new chairman on Monday, as it grapples with a major strategy reversal in an attempt to turn around a weak ...

Novo Nordisk's new CEO Maziar Mike Doustdar has been handed the reins to turn around the Wegovy-making firm's flagging sales ...

BP named Albert Manifold, the former boss of building materials producer CRH, as its new chairman on Monday, as it looks to address investor concerns about its strategy and weak share performance.

The pharma giant cut its guidance and named a new CEO, hoping to revive growth. Its stock fell as much as 30%, wiping almost $93 billion from its market value.